| Market Cap | 610M 525M 494M 451M 844M 57.62B 847M 5.84B 2.27B 29.56B 2.29B 2.24B 95.24B | P/E 2027 * |
-8.92x | P/E 2028 * | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 583M 502M 472M 432M 807M 55.09B 809M 5.58B 2.17B 28.26B 2.19B 2.14B 91.05B | EV / Sales 2027 * |
0.52x | EV / Sales 2028 * | 0.49x |
| Free-Float |
97.91% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Tilray, Inc.
| 1 day | +4.86% |
| Manager | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CEO | Chief Executive Officer | 67 | 2021-04-30 |
Carl Merton
DFI | Director of Finance/CFO | 57 | 2021-04-30 |
Roger Savell
ADM | Chief Administrative Officer | 64 | 2022-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Irwin Simon
CHM | Chairman | 67 | 2021-04-30 |
David Clanachan
BRD | Director/Board Member | 64 | 2021-04-29 |
John Herhalt
BRD | Director/Board Member | 69 | 2021-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.86% | -12.79% | - | - | 610M | ||
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | ||
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | ||
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | ||
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | ||
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | ||
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | ||
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | ||
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | ||
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | ||
| Average | -0.35% | +1.09% | +28.65% | +52.33% | 408.71B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.12B 966M 909M 830M 1.55B 106B 1.56B 10.74B 4.17B 54.39B 4.22B 4.12B 175B | 1.18B 1.01B 953M 870M 1.63B 111B 1.63B 11.26B 4.37B 57B 4.42B 4.32B 184B |
| Net income | -61.49M -52.91M -49.78M -45.48M -85.07M -5.81B -85.3M -588M -228M -2.98B -231M -226M -9.6B | -26.86M -23.12M -21.75M -19.87M -37.17M -2.54B -37.27M -257M -99.73M -1.3B -101M -98.68M -4.19B |
| Net Debt | -26.8M -23.06M -21.69M -19.82M -37.07M -2.53B -37.17M -256M -99.48M -1.3B -101M -98.43M -4.18B | -39.31M -33.82M -31.82M -29.07M -54.38M -3.71B -54.53M -376M -146M -1.9B -148M -144M -6.13B |
Employees
3,595
Sector
Pharmaceuticals
















